ERYTECH reports financial highlights for Q3 2015 Post author:admERY Post published:November 3, 2015 Post category:Newsroom ERYTECH reports cash balance and revenues for the third quarter of 2015. You Might Also Like ERYTECH strengthens its intellectual property position in the US April 21, 2015 ERYTECH Announces Results from TRYbeCA-1 Phase 3 Trial of Eryaspase in Patients with Second-line Advanced Pancreatic Cancer October 25, 2021 ERYTECH Announces the Hosting of a KOL Event as the TRYbeCA-1 Phase 3 Trial in Second-line Pancreatic Cancer Nears Complete Enrollment September 14, 2020
ERYTECH Announces Results from TRYbeCA-1 Phase 3 Trial of Eryaspase in Patients with Second-line Advanced Pancreatic Cancer October 25, 2021
ERYTECH Announces the Hosting of a KOL Event as the TRYbeCA-1 Phase 3 Trial in Second-line Pancreatic Cancer Nears Complete Enrollment September 14, 2020
